Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Erik Stoffersen"'
Autor:
Erik Stoffersen, Steen Ingeberg, Kaj Anker Jørgensen, Per Johan Sørensen, Göran Ahlbom, Mogens Hüttel
Publikováno v:
Scandinavian Journal of Haematology. 24:101-104
Antithrombin III activity and immunoreactive antithrombin III was determined in 31 patients before elective surgery and 3 h, 1, 3 and 7 d after. The values fell about 10--20% from 3 h to 3 d, but had returned to preoperative levels by the seventh day
Autor:
Erik Stoffersen, Kaj Anker Jørgensen
Publikováno v:
Scandinavian Journal of Haematology. 25:445-447
Publikováno v:
Thrombosis Research. 19:877-881
Autor:
Seigo Kohira, Jørn Dyerberg, T. Nishio, T. Imai, Karl D. Nolph, Tadao Tomoyoshi, Harold L. Moore, Charles A. Dinarello, Erik Stoffersen, H. J. Kornerup, David P. Bliss, Flemming Knudsen, Kenji Sawanishi, Arne Høj Nielsen, Shinichi Hosokawa
Publikováno v:
Blood Purification. 1:I-IV
Autor:
Erik Stoffersen, Kaj Anker Jørgensen
Publikováno v:
Pharmacological Research Communications. 13:579-586
Summary Hydrocortisone (HC) at concentrations above 0.5 mg/ml inhibited both ADP and thrombin induced aggregation as well as malondialdehyde (MDA) formation induced by thrombin in normal platelets, while even higher concentrations only produced minim
Publikováno v:
Blood Purification. 1:242-246
20 chronic hemodialysis patients were studied during two successive dialyses. Before the second dialysis patients ingested 320 mg acetylsalicylic acid (ASA). Hemodialysis was associated with a decreas
Publikováno v:
The Lancet. 312:117-119
Unlike arachidonic acid (eicosatetraenoic acid, C20:4omega-6, A.A.), eicosapentaenoic acid (C20:5omega-3, E.P.A.) does not induce platelet aggregation in human platelet-rich plasma (P.R.P.), probably because of the formation of thromboxane A3 (T.X.A3
Publikováno v:
Human Heredity. 32:49-51
The C3 phenotypes were determined by high-voltage agarose gel electrophoresis in 125 Greenland Eskimos. The frequency of the C3F gene was significantly lower than in a control group
Autor:
Erik Stoffersen, Giovanni Di Minno, Giovanni de Gaetano, N. Russell-Smith, Silvio Garattini, Salvador Moncada, R.J. Flower, Kaj Anker J o̸ rgensen
Publikováno v:
The Lancet. 312:1257-1259
Autor:
Erik Stoffersen, Jørn Dyerberg
Publikováno v:
Acta haematologica. 63(5)
The case history of a patient with moderate factor XII deficiency and recurrent deep vein thrombosis is described. A decreased resting fibrinolytic capacity suggests that ‘in vivo’ Hageman factor acts mainly as a promotor of clot dissolution. It